| 10-Q |
Report
| Data |
10-Q |
Nov 8, 2024 |
Sep 30, 2024 |
| 8-K |
Report
| Data |
8-K |
Nov 7, 2024 |
Nov 7, 2024 |
| 8-K |
Report
| Data |
8-K |
Nov 6, 2024 |
Nov 6, 2024 |
| 8-K |
Report
| Data |
8-K |
Nov 4, 2024 |
Nov 4, 2024 |
| 10-Q |
Report
| Data |
10-Q |
Aug 9, 2024 |
Jun 30, 2024 |
| 8-K |
Report
| Data |
8-K |
Aug 6, 2024 |
Aug 6, 2024 |
| 10-Q |
Report
| Data |
10-Q |
May 10, 2024 |
Mar 31, 2024 |
| 8-K |
Report
| Data |
8-K |
May 7, 2024 |
May 7, 2024 |
| 8-K |
Report
| Data |
8-K |
Apr 29, 2024 |
Apr 29, 2024 |
| 8-K |
Report
| Data |
8-K |
Mar 20, 2024 |
Mar 20, 2024 |
| 10-K |
Report
| Data |
10-K |
Mar 13, 2024 |
Dec 31, 2023 |
| 8-K |
Report
| Data |
8-K |
Mar 5, 2024 |
Mar 5, 2024 |
| SC 13G |
Report
|
SC 13G |
Feb 9, 2024 |
|
| 10-Q |
Report
| Data |
10-Q |
Nov 13, 2023 |
Sep 30, 2023 |
| 8-K |
Report
| Data |
8-K |
Nov 7, 2023 |
Nov 7, 2023 |
| 8-K |
Report
| Data |
8-K |
Oct 13, 2023 |
Oct 13, 2023 |
| 8-K |
Report
| Data |
8-K |
Sep 6, 2023 |
Sep 5, 2023 |
| 10-Q |
Report
| Data |
10-Q |
Aug 11, 2023 |
Jun 30, 2023 |
| 8-K |
Report
| Data |
8-K |
Aug 8, 2023 |
Aug 8, 2023 |
| 8-K |
Report
| Data |
8-K |
Jun 30, 2023 |
Jun 26, 2023 |
| 8-K |
Report
| Data |
8-K |
Jun 22, 2023 |
Jun 16, 2023 |
| 8-K |
Report
| Data |
8-K |
Jun 7, 2023 |
Jun 2, 2023 |
| 8-K |
Report
| Data |
8-K |
Jun 2, 2023 |
May 30, 2023 |
| 8-K |
Report
| Data |
8-K |
May 24, 2023 |
May 24, 2023 |
| 8-K |
Report
| Data |
8-K |
May 16, 2023 |
May 16, 2023 |
| 10-Q |
Report
| Data |
10-Q |
May 12, 2023 |
Mar 31, 2023 |
| 8-K |
Report
| Data |
8-K |
May 9, 2023 |
May 9, 2023 |
| 8-K |
Report
| Data |
8-K |
Apr 28, 2023 |
Apr 25, 2023 |
| 8-K |
Report
| Data |
8-K |
Apr 17, 2023 |
Apr 14, 2023 |
| 8-K |
Report
| Data |
8-K |
Apr 4, 2023 |
Apr 4, 2023 |
| 8-K |
Report
| Data |
8-K |
Mar 15, 2023 |
Mar 15, 2023 |
| 10-K |
Report
| Data |
10-K |
Mar 13, 2023 |
Dec 31, 2022 |
| 8-K |
Report
| Data |
8-K |
Mar 7, 2023 |
Mar 7, 2023 |
| SC 13G |
Report
|
SC 13G |
Feb 10, 2023 |
|
| 8-K |
Report
| Data |
8-K |
Jan 17, 2023 |
Jan 17, 2023 |
| 8-K |
Report
| Data |
8-K |
Dec 12, 2022 |
Dec 6, 2022 |
| 10-Q |
Report
| Data |
10-Q |
Nov 14, 2022 |
Sep 30, 2022 |
| 8-K |
Report
| Data |
8-K |
Nov 8, 2022 |
Nov 8, 2022 |
| 10-Q |
Report
| Data |
10-Q |
Aug 12, 2022 |
Jun 30, 2022 |
| 8-K |
Report
| Data |
8-K |
Aug 9, 2022 |
Aug 9, 2022 |
| 8-K |
Report
| Data |
8-K |
Jul 19, 2022 |
Jul 19, 2022 |
| 8-K |
Report
| Data |
8-K |
Jun 3, 2022 |
Jun 3, 2022 |
| 10-Q |
Report
| Data |
10-Q |
May 13, 2022 |
Mar 31, 2022 |
| 8-K |
Report
| Data |
8-K |
May 10, 2022 |
May 10, 2022 |
| 8-K |
Report
| Data |
8-K |
May 3, 2022 |
May 3, 2022 |
| 8-K |
Report
| Data |
8-K |
Apr 25, 2022 |
Apr 25, 2022 |
| 8-K |
Report
| Data |
8-K |
Mar 22, 2022 |
Mar 22, 2022 |
| 8-K/A |
Report
| Data |
8-K/A |
Mar 17, 2022 |
Mar 17, 2022 |
| 8-K |
Report
| Data |
8-K |
Mar 17, 2022 |
Mar 17, 2022 |
| 10-K |
Report
| Data |
10-K |
Mar 11, 2022 |
Dec 31, 2021 |
| 8-K |
Report
| Data |
8-K |
Mar 8, 2022 |
Mar 8, 2022 |
| SC 13G |
Report
|
SC 13G |
Feb 14, 2022 |
|
| SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Feb 8, 2022 |
|
| 8-K |
Report
|
8-K |
Jan 6, 2022 |
Jan 6, 2022 |
| 8-K |
Report
| Data |
8-K |
Jan 3, 2022 |
Dec 31, 2021 |
| 8-K |
Report
| Data |
8-K |
Dec 27, 2021 |
Dec 27, 2021 |
| 8-K |
Report
| Data |
8-K |
Dec 1, 2021 |
Nov 30, 2021 |
| 8-K |
Report
| Data |
8-K |
Nov 19, 2021 |
Nov 19, 2021 |
| 10-Q |
Report
| Data |
10-Q |
Nov 12, 2021 |
Sep 30, 2021 |
| 8-K |
Report
| Data |
8-K |
Nov 9, 2021 |
Nov 9, 2021 |
| 8-K |
Report
| Data |
8-K |
Nov 1, 2021 |
Nov 1, 2021 |
| 10-Q |
Report
| Data |
10-Q |
Aug 13, 2021 |
Jun 30, 2021 |
| 8-K |
Report
|
8-K |
Aug 10, 2021 |
Aug 10, 2021 |
| SC 13G/A |
Report
|
SC13GA CUMBERLAND PHARMA JUN 2021 |
Jul 9, 2021 |
|
| 8-K |
Report
|
8-K |
Jun 14, 2021 |
Jun 11, 2021 |
| 8-K |
Report
|
8-K |
May 14, 2021 |
May 14, 2021 |
| 10-Q |
Report
| Data |
10-Q |
May 14, 2021 |
Mar 31, 2021 |
| 8-K |
Report
|
8-K |
May 11, 2021 |
May 11, 2021 |
| 8-K |
Report
|
8-K |
Apr 30, 2021 |
Apr 30, 2021 |
| 10-K |
Report
| Data |
10-K |
Mar 12, 2021 |
Dec 31, 2020 |
| 8-K |
Report
|
8-K |
Mar 9, 2021 |
Mar 9, 2021 |
| SC 13G |
Report
|
SC 13G |
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
|
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
|
Feb 12, 2021 |
|
| 8-K |
Report
| Data |
8-K |
Dec 10, 2020 |
Dec 10, 2020 |
| 10-Q |
Report
| Data |
10-Q |
Nov 13, 2020 |
Sep 30, 2020 |
| 8-K |
Report
|
8-K |
Nov 10, 2020 |
Nov 10, 2020 |
| 8-K |
Report
|
8-K FOURTH AMENDMENT TO REVOLVING LINE OF CREDIT |
Oct 9, 2020 |
Oct 9, 2020 |
| 10-Q |
Report
| Data |
10-Q |
Aug 14, 2020 |
Jun 30, 2020 |
| 8-K |
Report
|
8-K |
Aug 11, 2020 |
Aug 11, 2020 |
| 10-Q/A |
Report
| Data |
10-Q/A |
Jul 24, 2020 |
Mar 31, 2020 |
| 8-K |
Report
|
8-K |
May 29, 2020 |
May 29, 2020 |
| 10-Q |
Report
| Data |
10-Q |
May 22, 2020 |
Mar 31, 2020 |
| 8-K |
Report
|
8-K |
May 20, 2020 |
May 20, 2020 |
| 8-K |
Report
|
8-K |
May 8, 2020 |
May 8, 2020 |
| 8-K |
Report
|
8-K |
May 8, 2020 |
May 8, 2020 |
| 8-K |
Report
|
8-K |
May 1, 2020 |
May 1, 2020 |
| 8-K |
Report
|
8-K |
Apr 21, 2020 |
Apr 21, 2020 |
| 10-K |
Report
| Data |
10-K |
Mar 20, 2020 |
Dec 31, 2019 |
| 8-K |
Report
|
8-K |
Mar 18, 2020 |
Mar 18, 2020 |
| SC 13G/A |
Report
|
|
Feb 14, 2020 |
|
| SC 13G/A |
Report
|
|
Feb 13, 2020 |
|
| SC 13G/A |
Report
|
SCHEDULE 13G/A |
Feb 12, 2020 |
|
| SC 13G |
Report
|
SC 13G |
Feb 7, 2020 |
|
| 8-K |
Report
|
8-K |
Jan 10, 2020 |
Jan 10, 2020 |
| 8-K |
Report
|
8-K CLINIGEN PRODUCTS |
Jan 3, 2020 |
Jan 3, 2020 |
| 8-K |
Report
|
8-K |
Dec 6, 2019 |
Dec 6, 2019 |
| 8-K |
Report
|
8-K |
Nov 29, 2019 |
Nov 25, 2019 |
| 10-Q |
Report
| Data |
10-Q |
Nov 13, 2019 |
Sep 30, 2019 |
| 8-K |
Report
|
8-K |
Nov 12, 2019 |
Nov 12, 2019 |
| 8-K |
Report
|
8-K |
Oct 18, 2019 |
Oct 15, 2019 |
| 8-K |
Report
|
8-K |
Sep 27, 2019 |
Sep 27, 2019 |
| 8-K |
Report
|
8-K |
Sep 20, 2019 |
Sep 20, 2019 |
| 8-K |
Report
|
8-K |
Sep 11, 2019 |
Sep 11, 2019 |
| 8-K |
Report
|
8-K |
Sep 10, 2019 |
Sep 10, 2019 |
| 8-K |
Report
|
8-K |
Aug 23, 2019 |
Aug 23, 2019 |
| 10-Q |
Report
| Data |
10-Q |
Aug 14, 2019 |
Jun 30, 2019 |
| 8-K |
Report
|
8-K |
Aug 14, 2019 |
Aug 14, 2019 |
| 10-Q |
Report
| Data |
10-Q |
May 15, 2019 |
Mar 31, 2019 |
| 8-K |
Report
|
8-K |
May 14, 2019 |
May 14, 2019 |
| 8-K |
Report
|
8-K |
Apr 26, 2019 |
Apr 26, 2019 |
| 10-K |
Report
| Data |
10-K |
Mar 12, 2019 |
Dec 31, 2018 |
| 8-K |
Report
|
8-K |
Feb 26, 2019 |
Feb 26, 2019 |
| SC 13G/A |
Report
|
SC13GA CPIX DEC18 |
Feb 14, 2019 |
|
| SC 13G/A |
Report
|
AMENDMENT NO. 2 |
Feb 13, 2019 |
|
| SC 13G |
Report
|
SC 13G |
Feb 8, 2019 |
|
| SC 13G/A |
Report
|
SCHEDULE 13G/A |
Feb 8, 2019 |
|
| 8-K |
Report
|
8-K |
Jan 28, 2019 |
Jan 28, 2019 |
| 8-K/A |
Report
|
8-K -VIBATIV FINANCIAL STATEMENTS |
Jan 28, 2019 |
Nov 16, 2018 |
| 8-K |
Report
|
8-K |
Jan 24, 2019 |
Jan 24, 2019 |
| 8-K |
Report
|
8-K |
Jan 14, 2019 |
Jan 11, 2019 |
| 8-K |
Report
|
8-K |
Dec 7, 2018 |
Dec 7, 2018 |
| 8-K |
Report
|
8-K - VIBATIV CLOSING |
Nov 16, 2018 |
Nov 16, 2018 |
| 10-Q |
Report
| Data |
10-Q |
Nov 14, 2018 |
Sep 30, 2018 |
| 8-K |
Report
|
8-K |
Nov 13, 2018 |
Nov 13, 2018 |
| 8-K |
Report
|
8-K |
Nov 6, 2018 |
Nov 6, 2018 |
| 8-K |
Report
|
8-K REVOLVER EXPANSION |
Oct 19, 2018 |
Oct 19, 2018 |
| 8-K |
Report
|
8-K CALDOLOR UPDATE 10012018 |
Oct 1, 2018 |
Oct 1, 2018 |
| 8-K |
Report
|
8-K 5.02 NEW DIRECTOR |
Sep 21, 2018 |
Sep 21, 2018 |
| 8-K |
Report
|
8-K |
Aug 14, 2018 |
Aug 14, 2018 |
| 10-Q |
Report
| Data |
10-Q |
Aug 14, 2018 |
Jun 30, 2018 |
| 8-K |
Report
|
8-K |
Aug 3, 2018 |
Aug 3, 2018 |
| 8-K |
Report
|
8-K INVESTOR PRESENTATION JUNE 2018 |
Jun 1, 2018 |
Jun 1, 2018 |
| 10-Q |
Report
| Data |
10-Q Q1 2018 |
May 9, 2018 |
Mar 31, 2018 |
| 8-K |
Report
|
8-K Q1 2018 EARNINGS RELEASE |
May 8, 2018 |
May 8, 2018 |
| 8-K |
Report
|
8-K - APRIL 2018 - VOTE OF ANNUAL SH MEETING |
Apr 27, 2018 |
Apr 27, 2018 |
| 8-K |
Report
|
8-K - CUMBERLAND ONCOLOGY |
Apr 13, 2018 |
Apr 13, 2018 |
| 8-K |
Report
|
8-K - H. PYLORI PUBLICATION |
Mar 30, 2018 |
Mar 30, 2018 |
| 8-K |
Report
|
8-K 2018 GEL AGREEMENT |
Mar 16, 2018 |
Mar 16, 2018 |
| 10-K |
Report
| Data |
10-K 2017 |
Mar 9, 2018 |
Dec 31, 2017 |
| 8-K |
Report
|
8-K 2017 EARNINGS RELEASE |
Mar 9, 2018 |
Mar 9, 2018 |
| SC 13G/A |
Report
|
|
Feb 13, 2018 |
|
| SC 13G/A |
Report
|
SC13GA CUMBERLAND PHARM DEC17 |
Feb 13, 2018 |
|
| SC 13G |
Report
|
SC 13G - AJ KAZIMI 2017 |
Feb 9, 2018 |
|
| SC 13G/A |
Report
|
SCHEDULE 13G/A |
Feb 9, 2018 |
|
| 8-K |
Report
|
8-K - AMIFOSTINE STUDY |
Feb 2, 2018 |
Feb 2, 2018 |
| 8-K |
Report
|
8-K - INVESTOR PRESENTATION DEC. 2017 |
Dec 8, 2017 |
Dec 8, 2017 |
| 10-Q |
Report
| Data |
10-Q Q3 2017 |
Nov 8, 2017 |
Sep 30, 2017 |
| 8-K |
Report
|
8-K - Q3 2017 EARNINGS RELEASE |
Nov 8, 2017 |
Nov 8, 2017 |
| 8-K |
Report
|
8-K - TOTECT LAUNCH |
Sep 29, 2017 |
Sep 29, 2017 |
| 8-K |
Report
|
8-K - CARDIOXANE SHIPMENTS |
Aug 11, 2017 |
Aug 11, 2017 |
| 8-K |
Report
|
8-K Q2 2017 8K |
Aug 9, 2017 |
Aug 9, 2017 |
| 10-Q |
Report
| Data |
10-Q 2017 Q2 |
Aug 9, 2017 |
Jun 30, 2017 |
| 8-K |
Report
|
8-K - NEW DEBT AGREEMENT |
Aug 2, 2017 |
Aug 2, 2017 |
| 8-K |
Report
| Data |
8-K - TOTECT US SHIPMENTS |
Aug 1, 2017 |
Aug 1, 2017 |
| 8-K |
Report
|
8-K - TOTECT FDA APPROVAL |
Jul 10, 2017 |
Jul 10, 2017 |
| SC 13G/A |
Report
|
SC13GA CPIX JUN17 |
Jul 10, 2017 |
|
| SC 13G |
Report
|
|
May 19, 2017 |
|
| 8-K |
Report
|
8-K Q1 2017 8K - EARNINGS RELEASE |
May 15, 2017 |
May 15, 2017 |
| 10-Q |
Report
| Data |
10-Q Q1 2017 |
May 15, 2017 |
Mar 31, 2017 |
| 8-K |
Report
|
8-K - KRISTALOSE CO-PROMOTION AGREEMENT |
Apr 28, 2017 |
Apr 28, 2017 |
| 8-K |
Report
|
8-K- APRIL 2016 VOTE OF ANNUAL SH MEETING |
Apr 28, 2017 |
Apr 28, 2017 |
| 8-K |
Report
|
8-K - CALDOLOR PRESS RELEASE |
Mar 31, 2017 |
Mar 31, 2017 |
| 8-K/A |
Report
|
8-K/A - CHANGES IN REGISTRANTS CERTIFYING ACCOUNTANT |
Mar 22, 2017 |
Mar 22, 2017 |
| 8-K |
Report
|
8-K - CHANGE OF AUDITORS |
Mar 16, 2017 |
Mar 16, 2017 |
| 10-K |
Report
| Data |
10-K 2016 |
Mar 13, 2017 |
Dec 31, 2016 |
| 8-K |
Report
|
8-K 2016 Q4 EARNINGS RELEASE |
Mar 10, 2017 |
Mar 10, 2017 |
| SC 13G/A |
Report
|
SC13GA CPIX DEC16 |
Feb 14, 2017 |
|
| 8-K |
Report
|
8-K - CALDOLOR PED FEVER STUDY |
Feb 10, 2017 |
Feb 10, 2017 |
| SC 13G |
Report
|
SC 13G - AJ KAZIMI 2016 |
Feb 10, 2017 |
|
| SC 13G |
Report
|
SCHEDULE 13G |
Feb 9, 2017 |
|
| 8-K |
Report
|
8-K - ACETADOTE IP UPDATE |
Feb 3, 2017 |
Feb 3, 2017 |
| 8-K |
Report
|
8-K - BOARD APPOINTMENT |
Jan 20, 2017 |
Jan 20, 2017 |
| 8-K |
Report
|
8-K - TOTECT AGREEMENT |
Jan 13, 2017 |
Jan 13, 2017 |
| 8-K |
Report
|
8-K - NORDIC AGREEMENT |
Nov 21, 2016 |
Nov 21, 2016 |
| 10-Q |
Report
| Data |
10-Q |
Nov 3, 2016 |
Sep 30, 2016 |
| 8-K |
Report
|
8-K - EARNINGS RELEASE |
Nov 3, 2016 |
Nov 3, 2016 |
| 8-K |
Report
|
8-K - ETHYOL US LAUNCH |
Sep 30, 2016 |
Sep 30, 2016 |
| 8-K |
Report
|
8-K - PORTABAN ANNOUNCEMENT |
Sep 16, 2016 |
Sep 16, 2016 |
| 8-K |
Report
|
8-K ETHYOL DISTRIBUTION |
Aug 26, 2016 |
Aug 26, 2016 |
| 8-K |
Report
|
8-K |
Aug 5, 2016 |
Aug 5, 2016 |
| 10-Q |
Report
| Data |
10-Q |
Aug 5, 2016 |
Jun 30, 2016 |
| 8-K |
Report
| Data |
8-K |
Jun 10, 2016 |
Jun 10, 2016 |
| 10-Q |
Report
| Data |
10-Q |
May 13, 2016 |
Mar 31, 2016 |
| 8-K |
Report
| Data |
8-K |
May 13, 2016 |
May 13, 2016 |
| 8-K |
Report
| Data |
8-K |
May 10, 2016 |
May 10, 2016 |
| 8-K |
Report
|
8-K - APRIL 2016 VOTE OF SHAREHOLDERS |
Apr 29, 2016 |
Apr 29, 2016 |
| 8-K |
Report
| Data |
8-K - VASCULAN |
Apr 29, 2016 |
Apr 29, 2016 |
| SC 13G/A |
Report
|
SC13GA CUMBERLAND PHARMA MAR16 |
Apr 8, 2016 |
|
| 10-K |
Report
| Data |
10-K |
Mar 14, 2016 |
Dec 31, 2015 |
| 8-K |
Report
|
8-K |
Mar 9, 2016 |
Mar 9, 2016 |
| SC 13G |
Report
|
SC 13G |
Feb 16, 2016 |
|
| SC 13G/A |
Report
|
SC13GA CUMBERLAND PHARMA DEC15 |
Feb 12, 2016 |
|
| SC 13G |
Report
|
SCHEDULE 13G |
Feb 9, 2016 |
|
| 8-K |
Report
|
8-K |
Feb 5, 2016 |
Feb 5, 2016 |
| 8-K |
Report
|
8-K MBONNERCFOAPPOINTMENT |
Feb 1, 2016 |
Jan 29, 2016 |
| 8-K |
Report
|
8-K |
Nov 24, 2015 |
Nov 24, 2015 |
| 8-K |
Report
|
8-K |
Nov 23, 2015 |
Nov 23, 2015 |
| 8-K |
Report
|
8-K |
Nov 20, 2015 |
Nov 20, 2015 |
| 8-K |
Report
|
8-K |
Nov 18, 2015 |
Nov 18, 2015 |
| 8-K |
Report
|
8-K |
Nov 9, 2015 |
Nov 9, 2015 |
| 10-Q |
Report
| Data |
10-Q |
Nov 6, 2015 |
Sep 30, 2015 |
| 8-K |
Report
|
8-K |
Nov 6, 2015 |
Nov 6, 2015 |
| 8-K |
Report
|
8-K CALDOLOR SAFETY 102015 |
Oct 30, 2015 |
Oct 30, 2015 |
| 8-K |
Report
|
8-K PIRAMAL |
Oct 16, 2015 |
Oct 16, 2015 |
| 8-K |
Report
|
8-K |
Oct 5, 2015 |
Oct 5, 2015 |
| 8-K |
Report
|
8-K |
Oct 2, 2015 |
Oct 2, 2015 |
| 8-K |
Report
|
8-K |
Sep 18, 2015 |
Sep 18, 2015 |
| 8-K |
Report
|
8-K |
Sep 15, 2015 |
Sep 15, 2015 |
| 10-Q |
Report
| Data |
10-Q |
Aug 7, 2015 |
Jun 30, 2015 |
| 8-K |
Report
|
8-K |
Aug 7, 2015 |
Aug 7, 2015 |
| 10-Q |
Report
| Data |
10-Q |
May 15, 2015 |
Mar 31, 2015 |
| 8-K |
Report
|
8-K |
May 8, 2015 |
May 8, 2015 |
| 8-K |
Report
|
8-K |
May 1, 2015 |
May 1, 2015 |
| 10-K |
Report
| Data |
10-K |
Mar 9, 2015 |
Dec 31, 2014 |
| 8-K |
Report
|
8-K - Q4 2014 EARNINGS RELEASE |
Mar 4, 2015 |
Mar 3, 2015 |
| 8-K |
Report
|
8-K |
Mar 4, 2015 |
Mar 4, 2015 |
| SC 13G |
Report
|
SC 13G |
Feb 13, 2015 |
|
| 8-K |
Report
|
8-K |
Feb 13, 2015 |
Feb 13, 2015 |
| SC 13G/A |
Report
|
SC13GA CPIX DEC14 |
Feb 13, 2015 |
|
| SC 13G/A |
Report
|
SC13GA CPIX DEC14 |
Feb 13, 2015 |
|
| SC 13G/A |
Report
|
SC13GA CPIX DEC14 |
Feb 13, 2015 |
|
| 8-K |
Report
|
8-K |
Dec 19, 2014 |
Dec 19, 2014 |
| 10-Q |
Report
| Data |
10-Q |
Nov 7, 2014 |
Sep 30, 2014 |
| 8-K |
Report
|
8-K |
Nov 7, 2014 |
Nov 7, 2014 |
| 10-Q |
Report
| Data |
10-Q |
Aug 8, 2014 |
Jun 30, 2014 |
| 8-K |
Report
|
8-K |
Aug 8, 2014 |
Aug 8, 2014 |
| 8-K |
Report
|
8-K |
Jul 2, 2014 |
Jul 2, 2014 |
| 8-K |
Report
|
8-K |
May 19, 2014 |
May 15, 2014 |
| 10-Q |
Report
| Data |
10-Q |
May 12, 2014 |
Mar 31, 2014 |
| 8-K |
Report
|
8-K |
May 9, 2014 |
May 9, 2014 |
| 8-K |
Report
|
8-K |
Apr 18, 2014 |
Apr 18, 2014 |
| 10-K |
Report
| Data |
10-K |
Mar 11, 2014 |
Dec 31, 2013 |
| 8-K |
Report
|
8-K |
Mar 7, 2014 |
Mar 7, 2014 |
| SC 13G |
Report
|
SC 13G |
Feb 14, 2014 |
|
| SC 13G/A |
Report
|
SC13GA CUMBERLAND PHARMACEUTICALS DEC13 |
Feb 14, 2014 |
|
| SC 13G/A |
Report
|
|
Feb 11, 2014 |
|
| SC 13G |
Report
|
SC 13G CUMBERLAND PHARMACEUTICALS OCT13 |
Nov 8, 2013 |
|
| 10-Q |
Report
| Data |
10-Q |
Nov 6, 2013 |
Sep 30, 2013 |
| 8-K |
Report
|
8-K |
Nov 6, 2013 |
Nov 6, 2013 |
| 8-K |
Report
|
8-K |
Oct 31, 2013 |
Oct 30, 2013 |
| 8-K |
Report
|
8-K |
Oct 7, 2013 |
Oct 4, 2013 |
| 10-Q |
Report
| Data |
10-Q |
Aug 9, 2013 |
Jun 30, 2013 |
| 8-K |
Report
|
8-K |
Aug 9, 2013 |
Aug 9, 2013 |
| 8-K |
Report
|
8-K |
Jun 14, 2013 |
Jun 14, 2013 |
| SC 13G/A |
Report
|
|
Jun 7, 2013 |
|
| 8-K |
Report
|
8-K |
Jun 3, 2013 |
Jun 3, 2013 |
| 10-Q |
Report
| Data |
10-Q |
May 8, 2013 |
Mar 31, 2013 |
| 8-K |
Report
|
8-K |
May 3, 2013 |
May 3, 2013 |
| 8-K |
Report
|
8-K |
Apr 19, 2013 |
Apr 19, 2013 |
| 8-K |
Report
|
8-K |
Apr 8, 2013 |
Apr 8, 2013 |
| 10-K |
Report
| Data |
10-K |
Mar 12, 2013 |
Dec 31, 2012 |
| 8-K |
Report
|
8-K |
Mar 4, 2013 |
Mar 1, 2013 |
| 8-K |
Report
|
8-K |
Feb 26, 2013 |
Feb 25, 2013 |
| 8-K |
Report
|
8-K |
Feb 21, 2013 |
Feb 21, 2013 |
| SC 13G |
Report
|
SC 13G |
Feb 14, 2013 |
|
| SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2013 |
|
| 8-K |
Report
|
8-K |
Feb 1, 2013 |
Feb 1, 2013 |
| SC 13G |
Report
|
|
Jan 30, 2013 |
|
| 8-K |
Report
|
8-K |
Jan 11, 2013 |
Jan 7, 2013 |
| SC 13G/A |
Report
|
CUMBERLAND PHARMACEUTICALS INC. SC 13G/A |
Jan 8, 2013 |
|
| 8-K |
Report
|
LIVE FILING |
Nov 30, 2012 |
Nov 29, 2012 |
| 8-K |
Report
|
LIVE FILING |
Nov 16, 2012 |
Nov 13, 2012 |
| 8-K |
Report
|
LIVE FILING |
Nov 13, 2012 |
Nov 12, 2012 |
| 8-K |
Report
|
LIVE FILING |
Nov 9, 2012 |
Nov 5, 2012 |
| 10-Q |
Report
| Data |
FORM 10-Q |
Nov 2, 2012 |
Sep 30, 2012 |
| 8-K |
Report
|
LIVE FILING |
Nov 1, 2012 |
Nov 1, 2012 |
| 8-K |
Report
|
LIVE FILING |
Sep 19, 2012 |
Sep 19, 2012 |
| 10-Q |
Report
| Data |
FORM 10-Q |
Aug 9, 2012 |
Jun 30, 2012 |
| 8-K |
Report
|
LIVE FILING |
Aug 2, 2012 |
Aug 2, 2012 |
| 8-K |
Report
|
LIVE FILING |
Jun 29, 2012 |
Jun 25, 2012 |
| 8-K |
Report
|
8-K |
May 24, 2012 |
May 18, 2012 |
| 8-K |
Report
|
LIVE FILING |
May 18, 2012 |
May 17, 2012 |
| 10-Q |
Report
| Data |
FORM 10-Q |
May 4, 2012 |
Mar 31, 2012 |
| 8-K |
Report
|
LIVE FILING |
May 3, 2012 |
May 3, 2012 |
| 8-K |
Report
|
LIVE FILING |
Apr 20, 2012 |
Apr 17, 2012 |
| 8-K |
Report
|
LIVE FILING |
Apr 11, 2012 |
Apr 5, 2012 |
| 10-K |
Report
| Data |
FORM 10-K |
Mar 7, 2012 |
Dec 31, 2011 |
| 8-K |
Report
|
LIVE FILING |
Mar 1, 2012 |
Feb 29, 2012 |
| SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2012 |
|
| SC 13G/A |
Report
|
AMENDMENT NO. 2 TO SCHEDULE 13G |
Feb 13, 2012 |
|
| SC 13G/A |
Report
|
CUMBERLAND PHARMACEUTICALS, INC. |
Jan 25, 2012 |
|
| 8-K |
Report
|
LIVE FILING |
Nov 22, 2011 |
Nov 15, 2011 |
| 10-Q |
Report
| Data |
10-Q |
Nov 7, 2011 |
Sep 30, 2011 |
| 8-K |
Report
|
LIVE FILING |
Nov 3, 2011 |
Nov 3, 2011 |
| 8-K |
Report
|
LIVE FILING |
Oct 18, 2011 |
Oct 12, 2011 |
| 10-Q |
Report
| Data |
FORM 10-Q |
Aug 8, 2011 |
Jun 30, 2011 |
| 8-K |
Report
|
LIVE FILING |
Aug 5, 2011 |
Aug 4, 2011 |
| 8-K |
Report
|
FORM 8-K |
Jun 24, 2011 |
Jun 20, 2010 |
| 10-Q |
Report
|
FORM 10-Q |
May 9, 2011 |
Mar 31, 2011 |
| 8-K |
Report
|
LIVE FILING |
May 5, 2011 |
May 4, 2011 |
| 8-K |
Report
|
LIVE FILING |
Apr 20, 2011 |
Apr 19, 2011 |
| 8-K |
Report
|
LIVE FILING |
Apr 4, 2011 |
Mar 29, 2011 |
| 10-K |
Report
|
FORM 10-K |
Mar 11, 2011 |
Dec 31, 2010 |
| 8-K |
Report
|
LIVE FILING |
Mar 9, 2011 |
Mar 8, 2011 |
| SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2011 |
|
| SC 13G |
Report
|
SCHEDULE 13G |
Feb 14, 2011 |
|
| SC 13G/A |
Report
|
CUMBERLAND PHARMACEUTICALS INC 13G ANNUAL 2010 |
Feb 11, 2011 |
|
| SC 13G/A |
Report
|
CUMBERLAND PHARMACEUTICALS INC. |
Jan 19, 2011 |
|
| 8-K |
Report
|
LIVE FILING |
Jan 6, 2011 |
Jan 1, 2011 |
| 10-Q |
Report
|
FORM 10-Q |
Nov 15, 2010 |
Sep 30, 2010 |
| 8-K |
Report
|
LIVE FILING |
Nov 12, 2010 |
Nov 11, 2010 |
| 8-K |
Report
|
FORM 8-K |
Oct 5, 2010 |
Sep 29, 2010 |
| 10-Q |
Report
|
FORM 10-Q |
Aug 16, 2010 |
Jun 30, 2010 |
| 8-K |
Report
|
LIVE FILING |
Aug 16, 2010 |
Aug 16, 2010 |
| 8-K |
Report
|
LIVE FILING |
Aug 13, 2010 |
Aug 9, 2010 |
| 8-K |
Report
|
LIVE FILING |
Jul 22, 2010 |
Jul 21, 2010 |
| SC 13G/A |
Report
|
|
Jun 9, 2010 |
|
| 10-Q |
Report
|
FORM 10-Q |
May 17, 2010 |
Mar 31, 2010 |
| 8-K |
Report
|
LIVE FILING |
May 14, 2010 |
May 13, 2010 |
| 8-K |
Report
|
LIVE FILING |
Apr 23, 2010 |
Apr 20, 2010 |
| 8-K |
Report
|
LIVE FILING |
Apr 6, 2010 |
Apr 1, 2010 |
| 8-K |
Report
|
LIVE FILING |
Mar 29, 2010 |
Mar 25, 2010 |
| 10-K |
Report
|
FORM 10-K |
Mar 19, 2010 |
Dec 31, 2009 |
| 8-K |
Report
|
LIVE FILING |
Mar 11, 2010 |
Mar 11, 2010 |
| SC 13G |
Report
|
SC 13G |
Feb 12, 2010 |
|
| SC 13G |
Report
|
CUMBERLAND PHARMACEUTICALS ANNUAL 13G FILING |
Feb 12, 2010 |
|
| SC 13G |
Report
|
|
Feb 12, 2010 |
|
| SC 13G |
Report
|
CUMBERLAND PHARMACEUTICALS INC. |
Jan 28, 2010 |
|
| 10-Q |
Report
|
FORM 10-Q |
Nov 12, 2009 |
Sep 30, 2009 |
| 10-Q |
Report
|
FORM 10-Q |
Aug 31, 2009 |
Jun 30, 2009 |